Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis-Reference-Cited by-同舟云学术

Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis

Author:

Li Jia¹²^ORCID,Wang Xiaoshuai¹²^ORCID,Ruan Guangfeng¹,Zhu Zhaohua¹^ORCID,Ding Changhai¹³⁴^ORCID

Affiliation:

1. Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China

2. Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China

3. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

4. Clinical Research Centre, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China

Funder

National Natural Science Foundation of China

GuangDong Basic and Applied Basic Research Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

Reference53 articles.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects of Disease-Modifying Osteoarthritis Drugs;Rheumatic Disease Clinics of North America;2024-08